May 2020, despite the continuing virus crisis, saw considerable venture and growth capital funding events.
Comparable to April, we tracked over $5 billion in new funding events during the month.
GRAIL, the biotech company developing a pan-cancer screening test designed to detect cancer early, led May financings with a $390 million Series D funding.
Other $100 million+ funding events in May included the following:
- Robinhood ($280 million) a provider of online/mobile stock brokerage services.
- Apeel Sciences ($250 million) a provider of edible products from natural plant extracts designed to eliminate food spoilage and reduce reliance on chemicals.
- Amwell ($194 million) a developer of a telehealth platform designed to improve patient outcomes.
- Contentsquare ($190 million) a developer of a digital experience insights optimization platform designed to help businesses understand how users are interacting.
- ASAPP ($185 million) a builder of AI-native products to solve large, complex, data-rich problems, by automating and augmenting human workflows, radically improving efficiency and effectiveness to empower people to be their best.
- Lime ($170 million) a scooter rental company.
- Marqeta ($150 million) an operator of an API payment platform designed to offer card issuing and payment processing services.
- Brex ($150 million) a provider of a corporate credit card designed to simplify the process for startups applying for credit cards.
- Rallybio ($145 million) a provider of biotechnological research and development services intended to transform the lives of patients with a devastating disease.
- Dispatch ($144 million) a developer of a web-based delivery and logistics management platform intended to optimize delivery operations and customer communication.
- Couchbase ($105 million) a developer of a cloud-based data platform designed to simplify mainframe and relational databases.
- Homeward ($105 million) a developer of a real estate management platform designed to simplify the process of purchasing homes online.
- Mindstrong ($100 million) a developer of a digital therapeutic platform intended to address personal, societal, and economic problems.
- Praxis Precision Medicines ($100 million) a developer of therapies intended for patients and families affected by complex and debilitating brain disorders.
- BioTech deals included GRAIL ($390 million), Rallybio ($145 million), Praxis Precision, Medicines ($100 million), Nautilus Biotechnology ($76 million), SQZ Biotechnologies ($65 million), HotSpot Therapeutics ($65 million), Immunomic Therapeutics ($61 million), Day One Biopharmaceuticals ($60 million), Amplyx Pharmaceuticals ($53 million), QurAlis ($42 million), Monte Rosa Therapeutics ($32 million), Octant ($30 million), GreenLight Biosciences ($17 million), Travecta Therapeutics ($15 million), Fountain Therapeutics ($6 million), Seraphina Therapeutics ($5 million).
- HealthTech deals included Oncology Analytics ($28 million), ChromaCode ($10 million), Stellar Health ($10 million), Genetesis ($9 million), Limbix ($9 million), Braid Health ($9 million), TimeDoc ($6 million), PathologyWatch ($5 million).
- Artificial Intelligence deals included Contentsquare ($190 million), ASAPP ($185 million), DefinedCrowd ($50 million), Covariant ($40 million), Nanit ($21 million), Deep Labs ($16 million), ThoughtTrace ($10 million), VergeSense ($9 million).
- Cybersecurity deals included Coalition ($90 million), Synack ($52 million), Confluera ($20 million), Source Defense ($10 million), Skyflow ($7 million), Clear Skye ($5 million), Finite State ($12 million).
- EdTech deals included GO1 ($40 million), Quizlet ($30 million), PresenceLearning ($27 million), Mos ($13 million), Emtrain ($8 million).
- FinTech deals included Robinhood ($280 million), Brex ($150 million), Stackin’ ($12 million), Splash Financial ($12 million), Treasury Prime ($9 million), Vise ($14 million).
- Productivity Software deals included UpKeep ($36 million), Lilt ($25 million), Bevy ($15 million), Jellyfish ($12 million), Brainbase ($8 million).
If you’re looking for outside funding to grow your company, please don’t hesitate to call us at (213) 927-3968 or fill out our contact form here.